Germany: Cinven launches public offer for Synlab at €10.00 per share

Private equity firm, Cinven, has made a public offer to shareholders of Synlab, a Germany based diagnostics company, to acquire the shares that it does not already own at €10.00 per share in cash, valuing the company at €2.24bn (US$2.37bn). Cinven already owns around 43% of the shares. The €10.00 offer price represents a 42%…